F.D.A. Authorizes Pfizer Boosters for 16- and 17-Year-Olds
The move clears the way for millions of teenagers to receive an additional shot, with a top regulator citing evidence that the effectiveness of two doses is waning in the age group.
View original article
Contributor: Sharon LaFraniere and Noah Weiland
